Last June, IBM and MDS Proteomics announced with fanfare their support of a database to hold information on all sorts of protein interactions — with other proteins, RNA, DNA, even small molecules. BIND, as the database is known, “is poised to become the definitive source of biomolecular interaction data,” MDS and IBM said at the time in a statement.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.